ENG19
Advanced solid tumors expressing EGFR
Phase 1/IIaActive
Key Facts
About EnGeneIC
Australian biotech leveraging nanocell cyto‑immunotherapy to deliver targeted cancer treatments.
View full company profileAdvanced solid tumors expressing EGFR
Australian biotech leveraging nanocell cyto‑immunotherapy to deliver targeted cancer treatments.
View full company profile